Arcturus Therapeutics Holdings Inc. (ARCT)
USD 14.82
(-5.79%)
USD 14.82
(-5.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.09 Million | 31.99 Million | -135.04 Million | -42.86 Million | -6.44 Million | -20.76 Million |
| Net Income | -29.72 Million | 9.34 Million | -203.67 Million | -72.14 Million | -25.99 Million | -21.78 Million |
| Depreciation & Amortization | 2.95 Million | 1.52 Million | 1.19 Million | 882 Thousand | 684 Thousand | 582 Thousand |
| Deferred income taxes | 31.53 Million | - | -1.09 Million | 263 Thousand | 25 Thousand | 302 Thousand |
| Stock-based compensation | 34.64 Million | 30.61 Million | 28.91 Million | 6.76 Million | 1.98 Million | 1.25 Million |
| Change in working capital | 7.38 Million | -12.55 Million | 31.23 Million | 21.21 Million | 15.98 Million | -1.15 Million |
| Other non-cash items | -64.89 Million | 3.06 Million | 8.38 Million | 162 Thousand | 873 Thousand | 38 Thousand |
| Investing Cash Flow | -2.9 Million | -7.72 Million | -3.4 Million | -1.74 Million | -818 Thousand | 22.13 Million |
| Investments in PPE | -2.9 Million | -7.72 Million | -3.4 Million | -1.74 Million | -818 Thousand | -1.47 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -6.59 Million |
| Sales/Maturities of investments | - | - | - | - | - | 30.2 Million |
| Other Investing Activities | -2.96 Million | -8.29 Million | -3.45 Million | -1.74 Million | -1.05 Million | 23.61 Million |
| Financing Cash Flow | -24.08 Million | -2.85 Million | 48.01 Million | 436.14 Million | 41.9 Million | 10.2 Million |
| Debt repayment | -27.36 Million | -5 Million | -46.59 Million | - | -4.94 Million | -9.87 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.27 Million | 411 Thousand | 515 Thousand | 423.81 Million | 36.82 Million | 332 Thousand |
| Other Financing Activities | -24.69 Million | 1.73 Million | 94.1 Million | 12.32 Million | 10.02 Million | 10.2 Million |
| Accounts receivables | -29.3 Million | 603 Thousand | -1.24 Million | 54 Thousand | 2.3 Million | -4 Million |
| Accounts payables | -2.23 Million | -3.11 Million | -769 Thousand | 4.81 Million | 3.15 Million | 578 Thousand |
| Inventory | - | - | 450 Thousand | 9.3 Million | 1.55 Million | 2.1 Million |
| Other working capital | 38.91 Million | -10.04 Million | 32.79 Million | 7.04 Million | 8.97 Million | 159 Thousand |
| Cash at beginning of period | 391.88 Million | 372.56 Million | 463 Million | 71.46 Million | 36.81 Million | 25.23 Million |
| Cash at end of period | 347 Million | 393.97 Million | 372.56 Million | 463 Million | 71.46 Million | 36.81 Million |
| Capital Expenditure | -2.9 Million | -7.72 Million | -3.4 Million | -1.74 Million | -818 Thousand | -1.47 Million |
| Effect of forex changes on cash | 209 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -44.87 Million | 21.4 Million | -90.43 Million | 391.54 Million | 34.64 Million | 11.57 Million |
| Free Cash Flow | -21 Million | 24.26 Million | -138.44 Million | -44.6 Million | -7.26 Million | -22.23 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.21 Million | -26.81 Million | -29.72 Million | -8.57 Million | -16.22 Million | -52.55 Million |
| Depreciation & Amortization | 900 Thousand | 904 Thousand | 2.95 Million | 815 Thousand | 827 Thousand | 737 Thousand |
| Deferred income taxes | - | - | 31.53 Million | -16.7 Million | - | 73.3 Million |
| Stock-based compensation | 9.42 Million | 10.08 Million | 34.64 Million | 8.81 Million | 9.26 Million | 8.38 Million |
| Change in working capital | -23.53 Million | 10.21 Million | 7.38 Million | 1.37 Million | -26.21 Million | 94.23 Million |
| Other non-cash items | 4.2 Million | 3.07 Million | -64.89 Million | 13.72 Million | -70 Thousand | -73.3 Million |
| Investing Cash Flow | -323.34 Thousand | -240 Thousand | -2.9 Million | -837.07 Thousand | -981 Thousand | -354 Thousand |
| Investments in PPE | -323.34 Thousand | -240 Thousand | -2.9 Million | -837.07 Thousand | -981 Thousand | -354 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -240 Thousand | -2.96 Million | -2.96 Million | - | - |
| Financing Cash Flow | 2.36 Million | 2.18 Million | -24.08 Million | -17.98 Million | 21.84 Million | 94 Thousand |
| Debt repayment | - | - | -27.36 Million | -19.27 Million | -19.79 Million | -439.73 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.36 Million | 2.18 Million | 3.27 Million | 1.28 Million | 1.78 Million | 92.48 Thousand |
| Other Financing Activities | 2.4 Million | 2.18 Million | -24.69 Million | 1.00 | 39.85 Million | 441.24 Thousand |
| Accounts receivables | 2.9 Million | 5 Million | -29.3 Million | 6.06 Million | -35.42 Million | 89.68 Million |
| Accounts payables | 4.69 Million | 3.86 Million | -2.23 Million | -12.32 Million | 4.9 Million | -6.19 Million |
| Inventory | - | - | - | 8.56 Million | -4.68 Million | -3.87 Million |
| Other working capital | -31.13 Million | -4.01 Million | 38.91 Million | 7.63 Million | 8.99 Million | 14.62 Million |
| Cash at beginning of period | 343.39 Million | 348.89 Million | 391.88 Million | 346.91 Million | 380.59 Million | 330.05 Million |
| Cash at end of period | 315.32 Million | 345.28 Million | 347 Million | 347 Million | 369.05 Million | 380.59 Million |
| Capital Expenditure | -323.34 Thousand | -240 Thousand | -2.9 Million | -837.07 Thousand | -981 Thousand | -354 Thousand |
| Effect of forex changes on cash | - | - | 209 Thousand | 19.45 Million | - | - |
| Net cash flow / Change in cash | -28.06 Million | -3.6 Million | -44.87 Million | 87 Thousand | -11.54 Million | 50.54 Million |
| Free Cash Flow | -30.17 Million | -5.79 Million | -21 Million | -1.38 Million | -33.38 Million | 50.45 Million |
IOFNF
6817
7361
CLPI
ABL
HYSG